Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

    Funding available for pilot projects researching rare diseases linked to understudied proteins, focusing on generating preliminary data and tools.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: February 16, 2027 (New) | March 16, 2027 (Resubmission) | June 16, 2027 (New) | July 16, 2027 (Resubmission) | October 16, 2027 (New) | November 16, 2027 (Resubmission; final closing)

    Funding Amounts: Up to $100,000 in direct costs for one year (excluding subcontract F&A)

    Summary: Supports pilot research generating preliminary data or tools to characterize eligible understudied proteins associated with rare diseases.

    Key Information: Projects must focus on proteins on the approved list within a rare-disease context; clinical trials are not allowed.


    Description

    This NIH R03 Small Grant Program supports discrete, well-defined projects that advance understanding of understudied proteins associated with rare diseases. Led by the National Center for Advancing Translational Sciences (NCATS), with five other participating NIH institutes, the program funds basic biochemical and biological work that can realistically be completed in one year with limited resources.

    Supported work includes pilot and feasibility studies, methodology and assay development, human-cell or animal models, protein characterization, reagent development, structure determination, and data mining with experimental validation. The goal is to produce preliminary data or research resources for subsequent grant applications or drug-discovery projects. Non-animal methodologies, including tissue chips, are encouraged. Preliminary data are not required, and early-stage investigators are encouraged to apply.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.